|
ethyl (3R,4R,5R)-5-chloro-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4R，5R）-5-氯-4-羥基-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸乙酯
|
|
|
ethyl (3R,4R,5S)-4-chloro-5-hydroxy-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4R，5S）-4-氯-5-羥基-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸乙酯
|
|
|
ethyl 3-(pentan-3-yloxy)benzoate
|
3-（戊烷-3-丙氧基）苯甲酸乙酯
|
1151665-78-9
|
|
ethyl (3R,4R,5S)-4-(tert-butylamino)-5-hydroxy-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4R，5S）-4-（叔丁胺）-5-羥基-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸乙酯
|
|
|
(S)-2-(Benzyloxy)propional
|
(S)-2-(芐氧基)丙醛
|
81445-44-5
|
|
N-[(E)-[(2S)-2-phenylmethoxypropylidene]amino]formamide
|
N-[(E)-[(2S)-2-苯基甲氧基亞丙基]氨基]甲酰胺
|
170985-84-9
|
|
2-(1-Ethylpropyl)-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one
|
2-（1-乙基丙基）-2,4-二氫-4-[4-[4-（4-羥基苯基）-1-哌嗪基]苯基]-3H-1,2,4-三唑-3-酮
|
212632-01-4
|
|
2-[(1S,2S)-1-Ethyl-2-hydroxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one
|
2-[（1S，2S）-1-乙基-2-羥丙基]-2,4-二氫-4-[4-[4-（4-羥基苯基）-1-哌嗪基]苯基]-3H-1,2,4-三唑-3-酮
|
687132-01-0
|
|
1,4-Anhydro-2,3,5-trideoxy-4-C-(2,4-difluorophenyl)-2-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-5-(1H-1,2,4-triazol-1-yl)-D-erythro-pentitol
|
1,4-脫水-2,3,5-三脫氧-4-C-（2,4-二氟苯基）-2-[[（4-甲基苯基）磺酰基]氧基]甲基]-5-（1H-1,2,4-三唑-1-基）-D-蘇氨酸奔騰醇
|
159811-30-0
|
|
Tosylhydrazine
|
對甲苯磺酰肼
|
1576-35-8
|
|
2-[2-(2,4-Difluorophenyl)-2-propen-1-yl]-1,3-propanediol
|
2-[2-（2,4-二氟苯基）-2-丙烯-1-基]-1,3-丙二醇
|
165115-73-1
|
|
Dimethyl 2-(2-(2,4-Difluorophenyl)Allyl)Malonate
|
2-（2,4-二氟苯基）烯丙基）丙二酸二甲酯
|
2134652-05-2
|
|
Posaconazole Impurity 51
|
泊沙康唑雜質(zhì)51
|
1941207-64-2
|
|
1-(4-Methoxyphenyl)-4-(4-nitrophenyl)piperazine
|
1-（4-甲氧基苯基）-4-（4-硝基苯基）哌嗪
|
74852-61-2
|
|
Phenyl N-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]carbamate
|
苯基N-[4-[4-（4-甲氧基苯基）-1-哌嗪基]苯基]氨基甲酸酯
|
74853-06-8
|
|
4-[4-(4-Methoxyphenyl)-1-piperazinyl]benzenamine
|
4-[4-（4-甲氧基苯基）-1-哌嗪基]苯胺
|
74852-62-3
|
|
((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2-fluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate
|
（（3S，5R）-5-（（1H-1,2,4-三唑-1-基）甲基）-5-（2-氟苯基）四氫呋喃-3-基）甲基4-甲基苯磺酸
|
|
|
(S)-3-((S)-4-(2,4-difluorophenyl)-2-(hydroxymethyl)pent-4-enoyl)-4-phenyloxazolidin-2-one
|
（S） -3-（（S）-4-（2,4-二氟苯基）-2-（羥甲基）戊-4-烯基）-4-苯基惡唑烷-2-酮
|
|
|
ethyl (3R,4S,5R)-4-acetoxy-5-(N-(tert-butyl)acetamido)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4S，5R）-4-乙酰氧基-5-（N-（叔丁基）乙酰胺）-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸乙酯
|
|
|
ethyl (1S,5R,6S)-7-(tert-butyl)-5-(pentan-3-yloxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylate
|
（1S，5R，6S）-7-（叔丁基）-5-（戊烷-3-氧基）-7-氮雜雙環(huán)[4.1.0]庚-3-烯-3-羧酸乙酯
|
|
|
ethyl (3R,4R,5R)-5-chloro-4-((methylsulfonyl)oxy)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4R，5R）-5-氯-4-（（甲磺酰）氧基）-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸乙酯
|
|
|
ethyl (3R,4S,5R)-5-(diallylamino)-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4S，5R）-5-（二烯丙基氨基）-4-羥基-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸乙酯
|
2254819-30-0
|
|
ethyl (3R,4R,5S)-4-acetoxy-5-(N-(tert-butyl)acetamido)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4R，5S）-4-乙酰氧基-5-（N-（叔丁基）乙酰胺）-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸乙酯
|
|
|
(3R,4R,5S)-4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid
|
（3R，4R，5S）-4-（叔丁基）乙酰胺）-5-（二烯丙基胺）-3-（戊烷-3-氧基）環(huán)己-1-烯-1-羧酸
|
|
|
1,3-Dimethyl-5,5-diallylhexahydropyrimidine-2,4,6-trione
|
1,3-二甲基-5,5-二烯丙基六氫嘧啶-2,4,6-三酮
|
722-97-4
|
|
4-N-Desacetyl-5-N-acetyl OseltaMivir
|
(3R,4R,5S)-5-乙酰胺基-4-氨基-3-(戊-3-基氧基)環(huán)己-1-烯-1-羧酸乙酯
|
956267-10-0
|
|
OSELTAMIVIR ACID
|
奧斯他偉酸
|
187227-45-8
|
|
OseltaMivir Acid Methyl Ester
|
磷酸奧司他韋EP雜質(zhì)E
|
208720-71-2
|
|
4-Acetamido-3-hydroxybenzoic acid
|
4-乙酰氨基-3-羥基苯甲酸
|
10098-40-5
|
|
3-Des(1-ethylpropoxy)-3-(1-Methylpropoxy) OseltaMivir
|
(3R,4R,5S)-4-(乙酰氨基)-5-氨基-3-(1-甲基丙氧基)-1-環(huán)己烯-1-羧酸乙酯
|
1052063-37-2
|
|
Aldicalcohol A-ring impurity 2
|
艾地A環(huán)雜質(zhì)2
|
|
|
AdicalciferolA-ring isomer
|
艾地A環(huán)1位異構(gòu)體
|
|
|
(1β,2α,3α,5Z,7E)-1,3-bis[(1,1-dimethylethyl)dimethylsilyloxy]-2-[3-[(1,1-dimethylethyl)dimethylsilyloxy]propoxy]-25-trimethylsilyloxy-9,10-secocholesta-5,7,10(19)-triene
|
艾地骨化醇中間體
|
342645-84-5
|
|
Aldicalcohol impurity
|
艾地骨化醇1位側(cè)鏈異構(gòu)體雜質(zhì)
|
1809782-41-9
|
|
Aldicalcohol intermediate impurity
|
艾地骨化醇中間體雜質(zhì)
|
|
|
Paricalcitol CD ring isomer
|
帕里CD環(huán)異構(gòu)體
|
|
|
(1S,3R,5E,7E)-1,3-Bis-[(tert-butyldiMethylsilyl)oxy]-9,10-secopregna-5,7,10-triene-20-carboxaldehyde
|
G6的N-1中間體
|
112828-13-4
|
|
(1R,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol
|
(1R,4R,E)-4 - ((1R,3AS,7AR,E)-4 - ((E)-2 - ((3S,5R
|
910133-34-5
|
|
Calcipotriene
|
卡泊三醇
|
112965-21-6
|
|
(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol
|
(1Α,3Β,5E,7E)-20-羥甲基-9,10-開環(huán)膽甾-1,3,-雙叔丁基二甲基硅氧基-5,7,10(19)-三烯
|
128387-35-9
|
|
(2E,4R)-4-[(1R,3aS,4E,7aR)-4-[(2E)-2-[(3S,5R)-3,5-Bis[[(tert-butyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl-1H-inden-1-yl]-1-cyclopropyl-2-penten-1-one
|
鈣泊三醇中間體-9
|
112849-17-9
|
|
Bis-TBDMS-trans-calcipotriol
|
雙(叔丁基二甲基硅基)-反式-鈣泊三醇
|
112849-27-1
|
|
{(1R,3aR,4S,7aR)-octahydro-1-[(S)-1-iodopropan-2-yl]-7a-methyl-1H-inden-4-yloxy}(tert-butyl)dimethylsilane
|
艾地CD環(huán)中間體
|
100928-05-0
|
|
(1R,3aR,4S,7aR)-octahydro-4-[(1,1-dimethylethyl)dimethylsilyloxy]-1-[(R)-2-hydroxy-1-methylethyl]-7a-methyl-1H-indene
|
CD二醇單保護甲基異構(gòu)體雜質(zhì)
|
171011-48-6
|
|
de-A,B-25-cholesten-8-one
|
艾地CD環(huán)雜質(zhì)
|
83076-51-1
|
|
Posaconazole Impurity(R,R,S,R)
|
泊沙康唑雜質(zhì)（R,R,S,R）
|
171228-51-6
|
|
ethyl (3R,4S,5R)-4,5-dihydroxy-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4S，5R）-4,5-二羥基-3-（戊烷-3-羥基）環(huán)己-1-烯-1-羧酸乙酯
|
2097777-49-4
|
|
ethyl (3R,4S,5R)-5-ethoxy-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
|
（3R，4S，5R）-5-乙氧基-4-羥基-3-（戊烷-3-丙氧基）環(huán)己-1-烯-1-羧酸乙酯
|
|
|
ShikiMic Acid Ethyl Ester
|
莽草酸乙酯
|
101769-63-5
|
|
ethyl (1S,5R,6S)-5-isopropoxy-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
|
（1S，5R，6S）-5-異丙氧基-7-氧雜環(huán)[4.1.0]庚-3-烯-3-羧酸乙酯
|
2382442-97-7
|
|
Ethyl 3,4-O-isopropylideneshikiMate
|
奧司他韋雜質(zhì)2
|
136994-78-0
|
|
3aR,7R,7aR)-2,2-Diethyl-3a,6,7,7a-tetrahydro-7-[(Methylsulfonyl)oxy]-1,3-benzodioxole-5-carboxylic Acid Ethyl Ester
|
3aR，7R，7aR）-2,2-二乙基-3a，6,7,7a-四氫-7-[（甲磺?；┭趸鵠-1,3-苯并二氧唑-5-羧酸乙酯
|
204254-90-0
|
|
(3R,4R,5R)-3-(1-Ethylpropoxy)-4-hydroxy-5-[(Methylsulfonyl)oxy]-1-cyclohexene-1-carboxylic Acid Ethyl Ester
|
奧司他韋雜質(zhì)64
|
204254-92-2
|
|
(1R,5S,6S)-rel-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Methyl Ester
|
奧司他韋雜質(zhì)6
|
1234858-94-6
|
|
ethyl (1S,5R,6S)-5-(sec-butoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
|
（1S，5R，6S）-5-（仲丁氧基）-7-惡唑環(huán)[4.1.0]庚-3-烯-3-羧酸乙酯
|
|
|
ethyl (3aR,7R,7aR)-2,2-dimethyl-7-((methylsulfonyl)oxy)-3a,6,7,7a-tetrahydrobenzo[d][1,3]dioxole-5-carboxylate
|
（3aR，7R，7aR）-2,2-二甲基-7-（（甲磺酰）氧基）-3a，6,7,7a-四氫苯并[d][1,3]二氧唑-5-羧酸乙酯
|
204254-84-2
|
|
1R,5R,6R)-5-(1-Ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester
|
（1R，5R，6R）-5-（1-乙基丙氧基）-7-氧雜雙環(huán)[4.1.0]庚-3-烯-3-羧酸乙基酯
|
1266663-89-1
|
|
Isavuconazole Impurity 14
|
艾沙康唑雜質(zhì) 14 （TLC標(biāo)準(zhǔn)）
|
2170932-49-5
|
|
Alfacalcidol
|
阿法骨化醇
|
41294-56-8
|
|
(5R,6R,7R,Z)-5,7-bis((tert-butyldimethylsilyl)oxy)-6-(3-((tert-butyldimethylsilyl)oxy)propoxy)-3-iodonona-2,8-dien-1-ol
|
艾地A環(huán)中間體
|
|
|
((Z)-2-((3R,4R,5S)-3,5-bis((tert-butyldimethylsilyl)oxy)-4-(3-((tert-butyldimethylsilyl)oxy)propoxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide
|
艾地A環(huán)3位異構(gòu)體
|
|
|
Adicalciferol A-ring corresponding isomer
|
艾地A環(huán)對應(yīng)異構(gòu)體
|
|
|
((Z)-2-((3R,4S,5R)-4,5-bis((tert-butyldimethylsilyl)oxy)-3-(3-((tert-butyldimethylsilyl)oxy)propoxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide
|
艾地A環(huán)1位側(cè)鏈異構(gòu)體
|
1809782-28-2
|
|
4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-2-(pentan-3-yl)-2,4-dihydro-3H-1,2,4-triazol-3-one
|
4-（4-（4-（（3R，5R）-5-（（1H-1,2,4-三唑-1-基）甲基）-5-（2,4-二氟苯基）四氫呋喃-3-基）甲氧基）苯基）哌嗪-1-基）苯基）-2-（戊烷-3-基）-2,4-二氫-3H-1,2,4-三唑-3-酮
|
|
|
Posaconazole Diastereoisomer 9 (S,S,S,S)
|
泊沙康唑非對映異構(gòu)體9
|
1246391-73-0
|
|
Posaconazole Diastereoisomer 1 (R,R,R,R)
|
泊沙康唑非對映異構(gòu)體1
|
170985-61-2
|
|
Posaconazole Impurity(R,S,S,S)
|
泊沙康唑雜質(zhì)（R,S,S,S）
|
2243785-96-6
|
|
Posaconazole Diastereoisomer 6 (R,R,R,S)
|
泊沙康唑非對映異構(gòu)體6
|
171228-50-5
|
|
Posaconazole Diastereoisomer 16(S,R,S,S)
|
泊沙康唑非對映異構(gòu)體16
|
213381-02-3
|
|
O-Benzyl Posaconazole
|
鄰芐基泊沙康唑
|
170985-86-1
|
|
1-[[(2R,3R)-2-(2,5-Difluorophenyl)-3-methyl-2-oxiranyl]methyl]-1H-1,2,4-triazole
|
1-[（2R，3R）-2-（2,5-二氟苯基）-3-甲基-2-環(huán)氧乙烷基]甲基]-1H-1,2,4-三唑
|
1062201-83-5
|
|
1-[[(2S,3S)-2-(2,5-Difluorophenyl)-3-methyl-2-oxiranyl]methyl]-1H-1,2,4-triazole
|
1-[（2S，3S）-2-（2,5-二氟苯基）-3-甲基-2-環(huán)氧乙烷基]甲基]-1H-1,2,4-三唑
|
|
|
Isavuconazole Impurity 2 （TLC）
|
艾沙康唑雜質(zhì) 14 （TLC標(biāo)準(zhǔn)）
|
|
|
Isavuconazole Impurity 6（TLC）
|
艾沙康唑雜質(zhì) 6 （TLC標(biāo)準(zhǔn)）
|
|
|
Posaconazole Diastereoisomer 7 (R,S,R,S)
|
泊沙康唑非對映異構(gòu)體7
|
213381-04-5
|
|
Posaconazole Impurity(S,R,S,R)
|
泊沙康唑雜質(zhì)（S,R,S,R）
|
213381-06-7
|
|
Posaconazole Impurity(S,S,S,R)
|
泊沙康唑雜質(zhì)（S,S,S,R）
|
2243785-99-9
|
|
Posaconazole Impurity(S,S,R,S)
|
泊沙康唑雜質(zhì)（S,S,R,S）
|
2243785-98-8
|
|
Posaconazole Diastereoisomer 3 (S,R,R,R)
|
泊沙康唑非對映異構(gòu)體3
|
1229428-89-0
|
|
(3S,4S)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine
|
（3S，4S）-N，4-二甲基-1-（苯甲基）-3-哌啶胺
|
1354621-59-2
|
|
N-Methyl-N-[(3S,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
N-甲基-N-[（3S，4S）-4-甲基-1-（苯甲基）-3-哌啶基]-7H吡咯[2,3-d]嘧啶-4-胺
|
1252883-90-1
|
|
N-Methyl-N-[(3S,4S)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
N-甲基-N-[（3S，4S）-4-甲基-3-哌啶基]-7H吡咯[2,3-d]嘧啶-4-胺
|
1260614-73-0
|
|
(3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
|
（3S，4S）-4-甲基-3-（甲基-7H-吡咯[2,3-d]嘧啶-4-基氨基）-β-氧代-1-哌啶丙烷腈
|
1092578-47-6
|
|
(3R,4R)-N,4-dimethyl-1-(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine
|
（3R，4R）-N，4-二甲基-1-（7-對甲苯基-7H-吡咯[2,3-d]嘧啶-4-基）哌啶-3-胺
|
|
|
Ethyl 2,4-dicyano-3-oxobutanoate
|
2,4-二氰基-3-氧代丁酸乙酯
|
861612-04-6
|
|
Tofacitinib Impurity 29 （scifinder）
|
托法替尼雜質(zhì)29
|
1616761-01-3
|
|
ethyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
|
乙基3-（（3R，4R）-4-甲基-3-（甲基（7H吡咯[2,3-d]嘧啶-4-基）氨基）哌啶-1-基）-3-氧丙酸酯
|
1675248-18-6
|
|
(2S,3S)-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
|
（2S，3S）-2-（2,5-二氟苯基）-1-（1H-1,2,4-三唑-1-基）丁烷-2,3-二醇
|
|
|
(2R,3S)-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
|
（2R，3S）-2-（2,5-二氟苯基）-1-（1H-1,2,4-三唑-1-基）丁烷-2,3-二醇
|
|
|
(2S,3R)-2-(2,5-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-dio
|
（2S，3R）-2-（2,5-二氟苯基）-1-（1H-1,2,4-三唑-1-基）丁烷-2,3-二醇
|
|
|
2-Naphthoic acid
|
2-萘甲酸
|
93-09-4
|
|
N-((3S,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
N-（（3S，4S）-1-芐基-4-甲基哌啶-3-基）-N-甲基-7-甲苯磺酰-7H-吡咯[2,3-d]嘧啶-4-胺
|
2504210-40-4
|
|
1-[[(2S,3R)-2-(2,5-Difluorophenyl)-3-methyl-2-oxiranyl]methyl]-1H-1,2,4-triazole
|
1-[（2S，3R）-2-（2,5-二氟苯基）-3-甲基-2-環(huán)氧乙烷基]甲基]-1H-1,2,4-三唑
|
|
|
Aldicalcohol A-ring impurity
|
艾地A環(huán)3位側(cè)鏈異構(gòu)體
|
|
|
Calcipotriol impurity
|
G6的雙鍵異構(gòu)雜質(zhì)
|
866406-02-2
|